AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ge, Y.
Right arrow Articles by Grossman, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ge, Y.
Right arrow Articles by Grossman, R. I.

BRAIN

Dynamic Susceptibility Contrast Perfusion MR Imaging of Multiple Sclerosis Lesions: Characterizing Hemodynamic Impairment and Inflammatory Activity

Yulin Gea, Meng Lawa, Glyn Johnsona, Joseph Herbertb, James S. Babba, Lois J. Mannona and Robert I. Grossmana

a Department of Radiology, New York University School of Medicine, New York, NY 10016
b Department of Neurology, Hospital for Joint Disease, New York University School of Medicine, New York, NY 10016

Address correspondence and reprint requests to Robert I. Grossman, Department of Radiology, New York University Medical Center, 550 First Avenue, IRM-229, New York City, NY 10016 (robert.grossman{at}med.nyu.edu)

BACKGROUND AND PURPOSE: Perfusion measurement in multiple sclerosis (MS) may cast light on the disease pathogenesis and lesion development since vascular pathology is frequently demonstrated in the disease. This study was performed to investigate the perfusion characteristics in MS lesions using dynamic susceptibility contrast MR imaging (DSC-MRI) to better understand the hemodynamic changes in MS.

METHODS: Seventeen patients with relapsing-remitting MS were studied with DSC-MRI. Perfusion measurements included cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT), were obtained in enhancing, non-enhancing lesions covered by DSC-MRI and contralateral normal appearing white matter (NAWM) in patients as well as normal white matter in seventeen control subjects.

RESULTS: DSC-MRI data demonstrated reduced perfusion with significantly prolonged MTT (P < 0.001) in lesions and NAWM in patients compared with normal white matter in controls. Compared to contralateral NAWM, enhancing lesions demonstrate increased CBF (P = 0.007) and CBV (P < 0.0001), indicating inflammation-mediated vasodilatation. A K means cluster analysis was performed and identifies approximately 63.8% of non-enhancing lesions (Class 1) with significantly decreased perfusion (P ≤ 0.0001) when compared with contralateral NAWM. In contrast, the remainder 36.2% non-enhancing lesions (Class 2) show increased CBV (P = 0.02) in a similar fashion to enhancing lesions and can be observed on quantitative color-coded maps even without blood-brain barrier breakdown.

CONCLUSION: DSC-MRI measurements demonstrate potential for investigating hemodynamic abnormalities that are associated with inflammatory activity, lesion reactivity and vascular compromise in MS lesions. Non-enhancing lesions showed both low and high perfusion suggesting microvascular abnormalities with hemodynamic impairment and inflammatory reactivity that cannot be seen on conventional MRI.




This article has been cited by other articles:


Home page
Mult SclerHome page
D. Soon, D. Tozer, D. Altmann, P. Tofts, and D. Miller
Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes
Multiple Sclerosis, August 1, 2007; 13(7): 884 - 894.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. Inglese, S.-J. Park, G. Johnson, J. S. Babb, L. Miles, H. Jaggi, J. Herbert, and R. I. Grossman
Deep Gray Matter Perfusion in Multiple Sclerosis: Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging at 3 T
Arch Neurol, February 1, 2007; 64(2): 196 - 202.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
Y. Ge
Multiple Sclerosis: The Role of MR Imaging
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1165 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. H. Taber, K. J. Black, and R. A. Hurley
Blood Flow Imaging of the Brain: 50 Years Experience
J Neuropsychiatry Clin Neurosci, November 1, 2005; 17(4): 441 - 446.
[Full Text] [PDF]